Covid19 Clinical Trial - A Novel Nomogram to Predict Severity of COVID-19

Status Completed

Clinical Trial Summary

Investigators use clinical data from a large sample of COVID-19 disease patients to screen out biomarkers associated with disease severity. Then, a novel nomogram model will be established to predict covid-19 disease severity, which could provide important assistance and supplement for clinical work. In the case of extremely shortage of front-line medical resources, patients with potential severe diseases will be timely treated with the help of the novel nomogram model.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04366024
Study type	Observational
Source	Xinqiao Hospital of Chongqing
Contact
Status	Completed
Phase
Start date	January 17, 2020
Completion date	December 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04984408` - Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.	Phase 3
Terminated	`NCT04642638` - Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure	Phase 2/Phase 3
Recruiting	`NCT04587323` - VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease
Completed	`NCT04682873` - A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus	Phase 3
Completed	`NCT04359212` - Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19
Completed	`NCT05603130` - Epidemiologic Register on Diabetes and COVID-19 in Tunisia
Completed	`NCT04830800` - A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC	Phase 1/Phase 2
Completed	`NCT04757792` - Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU
Active, not recruiting	`NCT04417257` - Study of LAU-7b for the Treatment of COVID-19 Disease in Adults	Phase 2/Phase 3
Recruiting	`NCT04522037` - Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients
Completed	`NCT04446377` - A Study of LAM-002A for the Prevention of Progression of COVID-19	Phase 2
Active, not recruiting	`NCT04969172` - A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection	Phase 2
Completed	`NCT04347369` - A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease
Completed	`NCT04787510` - COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
Completed	`NCT05329220` - ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2	Phase 3
Active, not recruiting	`NCT05077267` - ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects	Phase 2
Completed	`NCT04472013` - Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19
Active, not recruiting	`NCT04371354` - Outcomes of Covid-19 Protective Measures in Endoscopy
Not yet recruiting	`NCT04779359` - Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease